#1 Clinical Trials Search in Europe

Cefuroxime

This article explores the use of cefuroxime, a second-generation cephalosporin antibiotic, in various clinical trials. Cefuroxime is being studied for its effectiveness in preventing and treating infections across different medical scenarios, including post-surgical infections, pregnancy-related conditions, and pediatric care. The trials aim to optimize dosing regimens, compare administration methods, and assess safety profiles in diverse patient populations.

Table of Contents

What is Cefuroxime?

Cefuroxime is an antibiotic medication used to treat various bacterial infections. It belongs to a class of antibiotics called cephalosporins. Cefuroxime works by killing bacteria or preventing their growth[1]. This medication is also known by other names, including:

  • Cefuroxime axetil (oral form)
  • Ceftin (brand name)
  • Cefuroxime sodium (intravenous form)

Uses of Cefuroxime

Cefuroxime is used to treat a wide range of bacterial infections, including:

  • Urinary tract infections (UTIs): Cefuroxime is effective in treating and preventing UTIs, especially in pregnant women[1].
  • Respiratory tract infections: It can be used to treat infections of the lungs and airways[2].
  • Skin and soft tissue infections: Cefuroxime is effective against various skin infections[3].
  • Surgical site infections: It is commonly used as a preventive measure before and after surgery to reduce the risk of infections[3].
  • Lyme disease: Cefuroxime axetil is used to treat early Lyme disease, particularly the skin rash known as erythema migrans[4].

How Cefuroxime is Administered

Cefuroxime can be administered in several ways, depending on the type of infection and the patient’s condition:

  • Oral tablets: Cefuroxime axetil is available as oral tablets, typically taken twice daily for a prescribed period[4].
  • Intravenous (IV) injection: For more severe infections or in hospital settings, cefuroxime may be given as an IV injection[3].
  • Prophylactic use: Before surgery, cefuroxime is often given as a single dose to prevent infections. The timing and dosage may vary depending on the procedure and patient factors[5].

Effectiveness of Cefuroxime

Cefuroxime has been shown to be effective in treating various bacterial infections. Some key points about its effectiveness include:

  • In treating urinary tract infections during pregnancy, cefuroxime has been found to reduce the rate of bacteriuria (bacteria in urine) and related complications[1].
  • For surgical prophylaxis, cefuroxime is effective in reducing the risk of post-operative infections when administered before or during surgery[3].
  • In treating early Lyme disease, cefuroxime axetil has shown comparable effectiveness to doxycycline, another commonly used antibiotic[4].

Cefuroxime in Special Populations

Cefuroxime is used in various patient populations, including:

  • Pregnant women: Cefuroxime is considered safe for use during pregnancy and is often used to treat and prevent urinary tract infections in pregnant women[1].
  • Newborns and infants: Research is ongoing to determine the appropriate dosing and safety of cefuroxime in neonates and young infants[6].
  • Surgical patients: Cefuroxime is commonly used as a preventive antibiotic in various surgical procedures, including cardiac surgery and caesarean sections[7][5].

Side Effects and Safety

Like all medications, cefuroxime can cause side effects. Common side effects may include:

  • Nausea and vomiting
  • Diarrhea
  • Skin rash
  • Headache

In rare cases, more serious side effects can occur. It’s important to discuss potential side effects with your healthcare provider. Additionally, cefuroxime may interact with other medications, so inform your doctor about all medications you are taking[4].

Ongoing Research

Several clinical trials are currently investigating various aspects of cefuroxime use, including:

  • Optimal dosing strategies for surgical prophylaxis[3].
  • Effectiveness in treating specific infections, such as pyelonephritis (kidney infection) in pregnancy[2].
  • Use in combination with other antibiotics for enhanced effectiveness[8].
  • Impact on gut microbiota in newborns when used for caesarean section prophylaxis[5].

These ongoing studies aim to improve our understanding of cefuroxime’s effectiveness, safety, and optimal use in various clinical scenarios.

Study Focus Patient Population Key Interventions Primary Outcomes
Pyelonephritis in pregnancy Pregnant women Oral vs. IV cefuroxime Clinical improvement, negative urine culture
Colorectal surgery prophylaxis Adults undergoing colorectal surgery Standard bolus vs. bolus-continuous infusion cefuroxime Recruitment rates, healthcare-associated infections
Perioperative dosing in obesity Obese patients BMI-adjusted cefuroxime dosing Serum and tissue levels of cefuroxime
Pharmacokinetics in cardiac surgery infants Infants undergoing cardiac surgery Standard cefuroxime dosing Plasma concentrations of cefuroxime
Neonatal pharmacokinetics and safety Neonates Standard cefuroxime treatment Peak and trough plasma concentrations, adverse events
Cesarean section prophylaxis timing Women undergoing cesarean section Pre-incision vs. post-cord clamping cefuroxime Postoperative infection rates
Erythema migrans treatment Adults with erythema migrans Doxycycline vs. cefuroxime axetil Objective Lyme disease manifestations, post-Lyme symptoms
Post-hysterectomy infection prevention Women undergoing hysterectomy Cefuroxime + azithromycin vs. cefuroxime + placebo Number of deep infection episodes

FAQ

  • What is cefuroxime used for in these clinical trials? Cefuroxime is being studied for preventing post-surgical infections (e.g., after cesarean sections and colorectal surgery), treating pyelonephritis in pregnancy, and as prophylaxis for various procedures. It's also being evaluated for its effectiveness in neonatal care and treating erythema migrans.
  • How is cefuroxime administered in these studies? Administration methods vary by study, including intravenous injection, oral tablets, and in some cases, continuous infusion. The timing of administration (e.g., before or after surgical incision) is also being investigated.
  • What are some of the patient populations being studied? The trials include diverse groups such as pregnant women, neonates, infants undergoing cardiac surgery, obese patients, and adults with conditions like erythema migrans or those undergoing colorectal surgery or hysterectomy.
  • What are the main outcomes being measured in these trials? Key outcomes include infection rates, drug concentrations in blood and tissue, clinical improvement, adverse events, and in some cases, the impact on gut microbiota in newborns. Some studies also look at cost-effectiveness and quality of life measures.
  • Are there any comparisons being made with other antibiotics? Yes, some trials compare cefuroxime to other antibiotics. For example, one study compares doxycycline and cefuroxime axetil for treating erythema migrans. Another study evaluates the addition of azithromycin to cefuroxime for preventing post-hysterectomy infections.

Ongoing Clinical Trials on Cefuroxime

  • Study on Preoperative Antibiotics for Patients with Acute Cholecystitis: Comparing Ertapenem, Ciprofloxacin, and Cefuroxime

    Recruiting

    1 1 1 1
    Investigated drugs:
    Finland

  • Study on Optimizing Initial Dosing of Flucloxacillin and Drug Combination for Critically Ill Patients with Sepsis in the ICU

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Treating Perianal Fistulas Using Adipose Derived Regenerative Cells, Metronidazole, and Cefuroxime for Patients with Complex Perianal Fistulas

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study of cefuroxime and metronidazole to prevent infections after Whipple’s procedure in patients with high risk of bile contamination

    Recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands

  • Study on Early Oral Antibiotic Treatment for Vertebral Osteomyelitis Using Cefuroxime, Dicloxacillin, and Ceftriaxone for Adult Patients

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Outpatient Treatment Without Antibiotics or with Ciprofloxacin, Cefuroxime, Cefditoren Pivoxil, Amoxicillin/Clavulanic Acid, and Metronidazole in Adults with Acute Uncomplicated Diverticulitis

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Comparing local gentamicin or vancomycin hydrochloride to a drug combination for patients with diabetic foot osteomyelitis

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

  • Long-Term Safety and Efficacy Study of Botaretigene Sparoparvovec for Patients with X-Linked Retinitis Pigmentosa

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Belgium Denmark France Italy The Netherlands Spain

  • Study on Avibactam and Drug Combination for Treating Severe Infections in Patients

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Greece

Glossary

  • Cefuroxime: A second-generation cephalosporin antibiotic used to treat various bacterial infections or as prophylaxis to prevent infections in certain medical procedures.
  • Pyelonephritis: A type of urinary tract infection that affects one or both kidneys, often causing fever, back pain, and other symptoms.
  • Prophylaxis: Preventive treatment to stop a disease from occurring, often used in the context of giving antibiotics before surgery to prevent infections.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Erythema migrans: A expanding red rash that is often the first sign of Lyme disease, typically appearing at the site of a tick bite.
  • Cardiopulmonary bypass: A technique that temporarily takes over the function of the heart and lungs during surgery, maintaining circulation of blood and oxygen in the body.
  • Peritoneal dialysis: A treatment for kidney failure that uses the lining of your abdomen to filter blood inside your body.
  • Body mass index (BMI): A measure that uses your height and weight to work out if your weight is healthy, calculated by dividing weight in kilograms by height in meters squared.
  • Microbiota: The community of microorganisms living in a specific environment, such as the human gut.
  • Antibiogram: A profile of how sensitive a particular strain of bacteria is to different antibiotics, used to guide treatment choices.

References

  1. https://clinicaltrials.gov/study/NCT01507974
  2. https://clinicaltrials.gov/study/NCT06527560
  3. https://clinicaltrials.gov/study/NCT05609240
  4. https://clinicaltrials.gov/study/NCT01518192
  5. https://clinicaltrials.gov/study/NCT02072798
  6. https://clinicaltrials.gov/study/NCT05388747
  7. https://clinicaltrials.gov/study/NCT02850250
  8. https://clinicaltrials.gov/study/NCT05337566